Vimarsana
Biggest News Aggregation in the World

Page 5 - Integrative Screening Process News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrative Screening Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrative Screening Process Today - Breaking & Trending Today

IRLAB has Completed a Successful End-of-Phase 2 Meeting with the FDA on the Design of the Phase III - Vimarsana News

IRLAB has Completed a Successful End-of-Phase 2 Meeting with the FDA on the Design of the Phase III

GOTHENBURG, SWEDEN / ACCESSWIRE / February 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 22 February 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's recent End-of-Ph...

IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast ... - Vimarsana News

IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast ...

IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast ...

IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast - Vimarsana News

IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast

GOTHENBURG, SWEDEN / ACCESSWIRE / January 31, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the Year-end report for the period January-D...

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program - Vimarsana News

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program

GOTHENBURG, SWEDEN / ACCESSWIRE / January 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, January 3, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...

Source: yahoo.com
IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase ... - Vimarsana News

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase ...

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase ...